Healthcare - Biotechnology - NASDAQ - US
$ 2.5
-6.72 %
$ 4.94 M
Market Cap
-0.22
P/E
BALANCE SHEET
5.26 M
ASSETS
5.39 M
LIABILITIES
-128 K
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
180 Life Sciences Corp.
| Current Assets | 3.64 M |
| Cash & Short-Term Investments | 1.98 M |
| Receivables | 0 |
| Other Current Assets | 1.66 M |
| Non-Current Assets | 1.62 M |
| Long-Term Investments | 0 |
| PP&E | 0 |
| Other Non-Current Assets | 1.62 M |
| Current Liabilities | 5.06 M |
| Accounts Payable | 2.16 M |
| Short-Term Debt | 1.03 M |
| Other Current Liabilities | 1.87 M |
| Non-Current Liabilities | 325 K |
| Long-Term Debt | 19.9 K |
| Other Non-Current Liabilities | 305 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Cash & Cash Equivalents | 2.0 | 7.0 | 8.2 | 2.1 | 83.4 K | 0.6 | 0.4 |
| Short Term Investments | 0 | 0 | 0 | 0 | 11.9 | 118.2 | 116.6 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | (0.6) | 2.2 | 1.1 | 0.3 | 0 | 0 |
| Other Current Assets | 1.7 | 1.3 | 3.0 | 1.9 | 0.7 | 0.4 | 0 |
| Total Current Assets | 3.6 | 8.9 | 11.2 | 4.0 | 0.7 | 1.0 | 0.5 |
| PP&E | 0 | 0 | 0 | 0 | 54.3 K | 22.1 K | 0 |
| Intangible Assets | 1.6 | 10.7 | 14.5 | 14.6 | 14.7 | 0.4 | 0 |
| Goodwill | 0 | 0 | 37.0 | 36.9 | 36.4 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | (17.5) | 0 | 0 |
| Other Long Term Assets | 0 | (15.7) | (9.7) | (9.7) | 12.5 | 17.6 K | 116.6 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 5.3 | 19.7 | 62.7 | 55.5 | 51.9 | 1.5 | 117.1 |
| LIABILITIES | |||||||
| Accounts Payable | 2.2 | 1.8 | 0.6 | 8.5 | 4.1 | 0.2 | 0 |
| Short Term Debt | 1.0 | 1.3 | 1.9 | 3.7 | 3.5 | 0 | 0 |
| Other Current Liabilities | 1.9 | 2.5 | 17.2 | 9.2 | 2.0 | 8.8 | 0.1 |
| Total Current Liabilities | 5.1 | 5.7 | 19.7 | 21.4 | 9.6 | 9.1 | 0.2 |
| Long Term Debt | 19.9 K | 31.2 K | 48.2 K | 0.1 | 0 | 0 | 0 |
| Deferred Tax Income | 0.3 | 2.6 | 3.6 | 3.7 | 3.7 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 3.7 | 0 | 0 | 4.0 |
| Total Liabilities | 5.4 | 8.3 | 23.4 | 25.2 | 13.3 | 9.1 | 4.2 |
| EQUITY | |||||||
| Common Stock | 54 | 375 | 3.4 K | 2.62 K | 1.38 K | 1 | 107.8 |
| Retained Earnings | (127.3) | (107.4) | (68.7) | (48.4) | (37.5) | (12.1) | 0.1 |
| Other Accumulative Comprehensive Income/Loss | (2.9) | (2.9) | 0.8 | 0.6 | 0.2 | 0.3 | 0 |
| Total Equity | (0.1) | 11.3 | 39.3 | 30.3 | 38.6 | (7.7) | 5.0 |
| Total Liabilities and Equity | 5.3 | 19.7 | 62.7 | 55.5 | 51.9 | 1.5 | 117.1 |
| SHARES OUTSTANDING | |||||||
| Common Shares Outstanding | 0.4 | 100 K | 82 K | 47 K | 29 K | 10 K | 10 K |